Cardionovum

Be up
to date.

Latest press release

Bonn, Germany. November 16, 2022 – Data presented at Innovation session today at the CSC 2022 congress demonstrated an equivalent performance of the Xlimus® DES in terms of OCT derived endpoints than the Synergy™ DES, including Neointimal Volume and Neointimal Volume weighted by length at 6 months. Secondary endpoints, including other OCT parameters, such as in-stent Minimum Lumen Area (MLA) and percentage of strut coverage as well as clinical endpoints, showed no significant differences between the two groups in any of the evaluated parameters within the Xlimit RCT.

Prof. Matteo Tozzi (Varese, Italy) speaks to Vascular News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting in Barcelona (Spain) about his new study that analyzes the concentrations of paclitaxel in the bloodstream after the use of a Drug-Coated Balloons (DCBs) in AVFs.

We are proud to announce that we have received the authorization by the Secretaria de Salud and COFEPRIS to distribute APERTO® OTW in Mexico.

CARDIONOVUM® today announced the enrollment of the first patient in the International Hyper II Clinical Study

On June 8th, in Sankt Gertrauden hospital in Berlin, Germany, the first Signature RCT patient has been enrolled

Trial designed to evaluate non inferiority of XLIMUS DES vs SYNERGY EES in terms of reendothelialization assessed with OCT in patients undergoing percutaneous coronary intervention

Upcoming events

Cardionovum® at CIRSE 2024

Cardionovum® is pleased to invite you to visit us at booth #41.

Location:

CCL – Lisbon Congress Centre
Praça das Industrias 1
1300-307 Lisbon
Portugal

Date: Sep 14, 2024–Sep 18, 2024

Latest events

Cardionovum at CIRSE 2021

Cardionovum invites you to participate in 3 scientific presentations in the "Technology Innovations Videos":

  • Sunday 26th
    The SAFEPAX Technology presented by Dr. Michael Lichtenberg.

  • Monday 27th
    The Reflow Study at 2 years follow up. by Dr. Marc Bosiers.

  • Tuesday 28th
    Clinical outcomes with APERTO Balloon. by Dr. Matteo Tozzi.

Date: Sep 25, 2021–Sep 28, 2021

Learn more >>

Cardionovum at EuroPCR 18, 19, 20 May 2021

Cardionovum invites you to participate in on demand interviwes:

  • XLIMIT Trial RCT, with Dr. Luca Testa from Italy.
    Goal: to assess angiographic and clinical performance of the Xlimus Biodegradable Polymer Sirolumus-eluting stent versus a gold standard like Synergy Biodegradable Polymer Everolimus Stent in patients treated with percutaneous coronary angioplasty.

  • Hyper Registry with Dr. Alfonso Ileasi from Italy.
    Goal: Asses the clinical results after a Hybrid Approach in diffuse CAD lesions longer tan 28mm combinig Restore DCB and New generation DES.

Date: May 18, 2021–May 20, 2021

Learn more >>

Cardionovum - Meeting & Symposium at LINC 2020

Cardionovum participates at LINC
Leipzig Interventional Course
You are welcome to visit us at booth no. 19 c

Date: Jan 28, 2020–Jan 31, 2020

Location: Leipzig, Germany

Learn more >>

Visit website >>

go top